Peak6 Investments LLC Anavex Life Sciences Corp. Transaction History
Peak6 Investments LLC
- $43.5 Billion
- Q3 2024
A detailed history of Peak6 Investments LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Peak6 Investments LLC holds 30,000 shares of AVXL stock, worth $223,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$223,500% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AVXL
# of Institutions
154Shares Held
27.3MCall Options Held
515KPut Options Held
838K-
Black Rock Inc. New York, NY6.39MShares$47.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$35.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$22.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$14 Million0.0% of portfolio
-
Wealthgarden F.S. LLC El Segundo, CA910KShares$6.78 Million0.32% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $581M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...